GRTX · Categories · Form 4

GRTX - SEC Form 4 insider transactions

Galera Therapeutics Inc. (GRTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for GRTX

• 20d
  President and CEO Sorensen Mel returned 975 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 20d
  SEC Form 4 filed by Director Lokay Kevin G (tax liability)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 20d
  Director Chang Nancy T converted options into 661,309 shares and returned 47,434 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 20d
  Director Alleva Lawrence M returned 51 shares to the company, closing all direct ownership in the company (SEC Form 4) (for tax liability)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 20d
  SEC Form 4 filed by Chief Accounting Officer Sussman Joel F. (withholding obligation)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 20d
  Director Friedman Michael R. converted options into 2,989,399 shares and returned 41,631 shares to the company (SEC Form 4) (tax withholding)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 88d
  Large owner Emerald Bioventures, Llc converted options into 20,813,818 shares (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 138d
  SEC Form 4 filed by Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 138d
  SEC Form 4 filed by Chang Nancy T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 274d
  President and CEO Sorensen Mel sold $1,407 worth of shares (70,000 units at $0.02), decreasing direct ownership by 26% to 195,029 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 477d
  SEC Form 4 filed by Chief Accounting Officer Sussman Joel F.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 477d
  SEC Form 4 filed by President and CEO Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 545d
  SEC Form 4 filed by Director Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 545d
  SEC Form 4 filed by Director Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 545d
  SEC Form 4 filed by Director Chang Nancy T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 545d
  SEC Form 4 filed by Director Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 600d
  SEC Form 4 filed by Director Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 735d
  President and CEO Sorensen Mel sold $4,825 worth of shares (67,015 units at $0.07), decreasing direct ownership by 20% to 265,029 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1147d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1147d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1166d
  SEC Form 4 filed by Powell Michael

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1166d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1166d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1166d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1166d
  SEC Form 4 filed by Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1254d
  SEC Form 4 filed by Galera Therapeutics Inc.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1261d
  SEC Form 4: Degnan Chris bought $19,593 worth of shares (10,000 units at $1.96)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1261d
  SEC Form 4: Sorensen Mel bought $168,120 worth of shares (100,000 units at $1.68), increasing direct ownership by 43% to 332,044 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1274d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1274d
  SEC Form 4 filed by Kennedy Eugene P.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1274d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1274d
  SEC Form 4 filed by Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1274d
  SEC Form 4 filed by Beardsley Robert A

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1274d
  SEC Form 4 filed by Degnan Chris

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1372d
  SEC Form 4: Beardsley Robert A exercised 10,000 shares at a strike of $1.07, increasing direct ownership by 10% to 108,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1442d
  SEC Form 4: Beardsley Robert A exercised 10,000 shares at a strike of $1.07, increasing direct ownership by 11% to 98,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1453d
  SEC Form 4 filed by Kennedy Eugene P.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1498d
  SEC Form 4: Alleva Lawrence M gifted 4,000 shares, decreasing direct ownership by 63% to 2,325 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1512d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1531d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1531d
  SEC Form 4 filed by Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1531d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1531d
  SEC Form 4 filed by Powell Michael

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1531d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1637d
  SEC Form 4 filed by Beardsley Robert A

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1637d
  SEC Form 4 filed by Degnan Chris

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1637d
  SEC Form 4 filed by Holmlund Jon T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1637d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1637d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1637d
  SEC Form 4 filed by Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1709d
  SEC Form 4: West Linda bought $54,804 worth of shares (20,000 units at $2.74), increasing direct ownership by 50% to 60,000 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1709d
  SEC Form 4: Beardsley Robert A exercised 20,000 shares at a strike of $1.07, increasing direct ownership by 29% to 88,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1778d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1778d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1817d
  SEC Form 4: Holmlund Jon T sold $404,498 worth of Common Stock (47,756 units at $8.47) and exercised 47,756 units of Common Stock at a strike of $2.43

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1876d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1876d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1876d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1895d
  SEC Form 4 filed by LOKAY KEVIN G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1895d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)

Other GRTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends